Cancer Research UK and Cancer Research Technology Initiate Clinical of Astex Drug
Posted on January 16, 2013 at 21:15 PM EST
Astex Pharmaceuticals (NASDAQ: ASTX ) today announced that collaborators Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. The 'master-switch' experimental drug, owned by Astex Pharmaceuticals,